Bacillus Clausii PCD Pharma Franchise Company

Cafoli Lifecare offers a Bacillus Clausii probiotic range of 4 formulations across rota caps and oral suspension, manufactured in WHO-GMP certified facilities. Distributors in the fast-growing probiotic and gut-health segment can secure district-wise monopoly franchise rights with full promotional support.

What is Bacillus Clausii?

Bacillus clausii is a spore-forming probiotic bacterium that survives gastric acid and colonises the intestine to help restore normal gut microflora. It is widely used to treat and prevent acute diarrhoea, antibiotic-associated diarrhoea and to support recovery of intestinal flora during and after antibiotic therapy. Reference: PubMed - Bacillus clausii in diarrhoea.

Available Forms

The Cafoli Bacillus Clausii portfolio is available as Rota Caps and oral Suspension, covering both adult and paediatric use. Contact us for current pack presentations and trade offers on each form.

Therapeutic Applications

Bacillus clausii is prescribed for acute and chronic diarrhoea, antibiotic-associated diarrhoea, and restoration of gut flora in both children and adults. Prescribers include paediatricians, gastroenterologists and general physicians.

Why Bacillus Clausii is a High-Potential Molecule for Distributors

Probiotics are one of the fastest-growing OTC-adjacent categories in India, and Bacillus clausii is a paediatrician favourite because the spore suspension is convenient for children and is co-prescribed with almost every antibiotic course. That co-prescription pattern drives high prescription volume and steady repeat sales, making it a reliable everyday earner for distributors.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers monopoly franchise rights, WHO-GMP certified manufacturing, DCGI-approved formulations, a network of 1000+ franchise partners across India, and free promotional inputs.

References

1. PubMed: Bacillus clausii in diarrhoea
2. PMC: Bacillus clausii probiotic reviews
3. MedlinePlus: Probiotics